Search Results - "Hicks, J. R"

The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate) by Alipour, R., Jackson, P., Bressel, M., Hogg, A., Callahan, J., Hicks, R. J., Kong, G.

“…Peptide Receptor Radionuclide Therapy (PRRT) delivers targeted radiation to Somatostatin Receptor (SSR) expressing Neuroendocrine Neoplasms (NEN). We sought to…”
Get full text

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [ 18 F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors by Lopci, E, Aide, N, Dimitrakopoulou-Strauss, A, Dercle, L, Iravani, A, Seban, R D, Sachpekidis, C, Humbert, O, Gheysens, O, Glaudemans, A W J M, Weber, W A, Van den Abbeele, A D, Wahl, R L, Scott, A M, Pandit-Taskar, N, Hicks, R J

“…Response assessment in the context of immunomodulatory treatments represents a major challenge for the medical imaging community and requires a…”
Get full text

Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy by Cheah, C Y, Hofman, M S, Dickinson, M, Wirth, A, Westerman, D, Harrison, S J, Burbury, K, Wolf, M, Januszewicz, H, Herbert, K, Prince, H M, Carney, D A, Ritchie, D S, Hicks, R J, Seymour, J F

“…Background: The usefulness of positron emission tomography with computed tomography (PET–CT) in the surveillance of patients with diffuse large B-cell lymphoma…”
Get full text

MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome by Carne, R. P., O'Brien, T. J., Kilpatrick, C. J., MacGregor, L. R., Hicks, R. J., Murphy, M. A., Bowden, S. C., Kaye, A. H., Cook, M. J.

“…Most patients with non-lesional temporal lobe epilepsy (NLTLE) will have the findings of hippocampal sclerosis (HS) on a high resolution MRI. However, a…”
Get full text

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer by Winton, E de, Heriot, A G, Ng, M, Hicks, R J, Hogg, A, Milner, A, Leong, T, Fay, M, MacKay, J, Drummond, E, Ngan, S Y

“…Accurate inguinal and pelvic nodal staging in anal cancer is important for the prognosis and planning of radiation fields. There is evidence for the role of…”
Get full text

A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma by Lewin, J, Khamly, K K, Young, R J, Mitchell, C, Hicks, R J, Toner, G C, Ngan, S Y K, Chander, S, Powell, G J, Herschtal, A, Te Marvelde, L, Desai, J, Choong, P F M, Stacker, S A, Achen, M G, Ferris, N, Fox, S, Slavin, J, Thomas, D M

“…Background: Preoperative radiotherapy (RT) is commonly used to treat localised soft-tissue sarcomas (STS). Hypoxia is an important determinant of…”
Get full text

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy by Day, F L, Link, E, Ngan, S, Leong, T, Moodie, K, Lynch, C, Michael, M, Winton, E de, Hogg, A, Hicks, R J, Heriot, A

“…Background: The aim was to investigate the correlation between 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) metabolic response to…”
Get full text

The Impact of 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography on the Staging and Management of Primary Rectal Cancer by Davey, K., Heriot, A. G., Mackay, J., Drummond, E., Hogg, A., Ngan, S., Milner, A. D., Hicks, R. J.

“…Purpose 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) has a role in recurrent colorectal cancer. This study was designed…”
Get full text

Susceptibility to infection and pathogenicity of White Spot Disease (WSD) in non-model crustacean host taxa from temperate regions by Bateman, K.S., Tew, I., French, C., Hicks, R.J., Martin, P., Munro, J., Stentiford, G.D.

“…[Display omitted] ► Universal susceptibility to WSSV infection in a range of European decapod crustaceans. ► Relative degree of susceptibility varied…”
Get full text

Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome by Yeung, J. M. C, Kalff, V, Hicks, R. J, Drummond, E, Link, E, Taouk, Y, Michael, M, Ngan, S, Lynch, A. C, Heriot, A. G

“…BACKGROUND:Complete pathological response has proven prognostic benefits in patients with locally advanced rectal cancer treated with neoadjuvant…”
Get full text

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma by Ritchie, D, Mileshkin, L, Wall, D, Bartholeyns, J, Thompson, M, Coverdale, J, Lau, E, Wong, J, Eu, P, Hicks, R J, Prince, H M

“…Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and…”
Get full text

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 by Lopci, E., Hicks, R. J., Dimitrakopoulou-Strauss, A., Dercle, L., Iravani, A., Seban, R. D., Sachpekidis, C., Humbert, O., Gheysens, O., Glaudemans, A. W. J. M., Weber, W., Wahl, R. L., Scott, A. M., Pandit-Taskar, N., Aide, N.

“…Purpose The goal of this guideline/procedure standard is to assist nuclear medicine physicians, other nuclear medicine professionals, oncologists or other…”
Get full text

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging by Douglas, A. P., Thursky, K. A., Worth, L. J., Drummond, E., Hogg, A., Hicks, R. J., Slavin, M. A.

“…Purpose Invasive fungal infections (IFIs) are common in immunocompromised patients. While early diagnosis can reduce otherwise high morbidity and mortality,…”
Get full text

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA by Tan, L., Sandhu, S., Lee, R.J., Li, J., Callahan, J., Ftouni, S., Dhomen, N., Middlehurst, P., Wallace, A., Raleigh, J., Hatzimihalis, A., Henderson, M.A., Shackleton, M., Haydon, A., Mar, V., Gyorki, D.E., Oudit, D., Dawson, M.A., Hicks, R.J., Lorigan, P., McArthur, G.A., Marais, R., Wong, S.Q., Dawson, S.-J.

“…The advent of effective adjuvant therapies for patients with resected melanoma has highlighted the need to stratify patients based on risk of relapse given the…”
Get full text

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial by LOI, S, NGAN, S. Y. K, RISCHIN, D, HICKS, R. J, ATUKESH, B, MITCHELL, P, MICHAEL, M, ZALCBERG, J, LEONG, T, LIM-JOON, D, MACKAY, J

“…The aim of this study was to define the recommended dose of oxaliplatin when combined with infusional 5-fluorouracil (5-FU) and concurrent pelvic radiotherapy…”
Get full text

Design of environmentally friendly fiberglass compositions: ternary eutectic SiO2–Al2O3–CaO compositions, structures and properties by Wallenberger, F.T., Hicks, R.J., Bierhals, A.T.

“…Incumbent E-glass compositions, which are used for the manufacture of reinforcing fibers for structural composites (e.g., in automotive applications) and for…”
Get full text

Life is not black and white, nor just Shades of Gray by Beyer, T., Hicks, R. J., Freudenberg, L. S.

Get full text

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma by Lewin, J., Sayers, L., Kee, D., Walpole, I., Sanelli, A., te Marvelde, L., Herschtal, A., Spillane, J., Gyorki, D., Speakman, D., Estall, V., Donahoe, S., Pohl, M., Pope, K., Chua, M., Sandhu, S., McArthur, G.A., McCormack, C.J., Henderson, M., Hicks, R.J., Shackleton, M.

“…As early detection of recurrent melanoma maximizes treatment options, patients usually undergo post-operative imaging surveillance, increasingly with…”
Get full text

Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab by Bishton, M.J., Leahy, M.F., Hicks, R.J., Turner, J.H., McQuillan, A.D., Seymour, J.F.

“…Small series suggest retreatment of indolent lymphomas with murine anti-CD20 radioimmunotherapy is effective. The longer half-life of iodine-131…”
Get full text

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy by Hicks, R J

“…Imaging of neuroendocrine tumours (NET) poses significant challenges because of the heterogeneous biology of the tumours that are represented by this class of…”
Get full text